Income Statement
BRIDGEBIO PHARMA, INC.
BBIO
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY |
|---|---|---|---|---|---|---|---|
|
Revenue
|
502.08 | 221.90 | 9.30 | 77.65 | 69.72 | 8.25 | 40.56 |
|
Cost of Revenue
|
20.96 | 3.88 | 2.45 | - | 2.74 | - | - |
|
Gross Profit
|
481.11 | 218.02 | 6.86 | 77.65 | 66.98 | 8.25 | 40.56 |
|
Operating Expenses
|
983.18 | 795.39 | 606.30 | 542.65 | 643.23 | 482.73 | 306.80 |
|
Research & Development
|
451.95 | 506.46 | 455.71 | 399.46 | 451.02 | 337.05 | 209.95 |
|
Selling, General & Administrative
|
531.23 | 288.93 | 150.59 | 143.19 | 192.21 | 145.68 | 94.35 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - |
|
Operating Income
|
-502.06 | -577.37 | -599.44 | -465.00 | -576.25 | -474.48 | -266.24 |
|
Non-Operating Income
|
-209.09 | 50.78 | -45.88 | 27.55 | -9.82 | -31.01 | -22.35 |
|
Interest Income
|
19.85 | 17.25 | 18.04 | 7.54 | 1.13 | 4.02 | 8.92 |
|
Interest Expense
|
44.50 | 54.80 | 81.29 | 80.44 | 46.78 | 36.66 | 8.77 |
|
Other Non-Op Income / Expense
|
-35.10 | -31.18 | 17.37 | -7.50 | 35.82 | 1.63 | 0.20 |
|
Income Before Tax
|
-732.50 | -542.19 | - | - | - | 505.49 | 288.59 |
|
Income Tax Expense
|
0.44 | 1.15 | - | - | - | - | - |
|
Non-Controlling Interest
|
-8.01 | -7.59 | -10.05 | -3.47 | -23.92 | -56.76 | -28.00 |
|
Net Income
|
-732.94 | -543.35 | -653.25 | -484.65 | -586.45 | -505.49 | -288.59 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY |
|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - |
|
EBITDA
|
-496.63 | -571.29 | -592.95 | -458.23 | -570.41 | -474.48 | -266.24 |
|
Earnings Per Share (Basic)
|
-3.78 | -2.88 | -3.95 | -3.26 | - | - | - |
|
Diluted EPS
|
-3.78 | -2.88 | -3.95 | -3.26 | - | - | - |
|
Weighted Average Shares
|
191.53 | 186.08 | 162.79 | 147.47 | - | - | - |
|
Diluted Weighted Avg Shares
|
191.53 | 186.08 | 162.79 | 147.47 | - | - | - |
|
Comprehensive Income
|
-724.93 | -535.79 | -642.84 | -481.38 | -562.86 | -448.79 | -260.33 |